Saini, Chhavi http://orcid.org/0000-0002-4761-5905
Davies, Emma C.
Ung, Lawson
Chodosh, James http://orcid.org/0000-0002-7463-1599
Ciolino, Joseph B.
Jurkunas, Ula V.
Paschalis, Eleftherios I.
Pineda, Roberto
Saeed, Hajirah N.
Yin, Jia http://orcid.org/0000-0003-1340-6758
Shen, Lucy Q. http://orcid.org/0000-0002-0360-1296
Funding for this research was provided by:
Boston Keratoprosthesis Fund, Massachusetts Eye and Ear, Boston, MA.
Article History
Received: 10 January 2022
Revised: 3 October 2022
Accepted: 18 October 2022
First Online: 3 November 2022
Competing interests
: CS is supported by the Boston Keratoprosthesis Fund, Massachusetts Eye and Ear, Boston. LU is supported in part by the Dozoretz Family Private Foundation. JC is a consultant for the US Food and Drug Administration. JBC is a consultant for ORA System, TherOptix and Fontana and, has intellectual property and equity interest in TherOptix and Fontana. RP is a consultant for Sanofi Genzyme and receives royalties from Elsevier. JY is a consultant for Kera Therapeutics and has equity interest in Kera Therapeutics. LQC received research support from Topcon and is a consultant for FireCyte Therapeutics and AbbVie. ECD, EIP, and HNS declare no potential competing interests.